过去一年中添加的文章，按日期排序
[HTML][HTML] Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS–real-world data
K Schönfelder, L Kühne… - BMC …, 2024 - bmcnephrol.biomedcentral.com
2 天前 - … The complement factor 5 (C5)-inhibitor eculizumab has been established as
standard-of-care for the treatment of atypical hemolytic uremic syndrome (aHUS). In 2021, the long-…
standard-of-care for the treatment of atypical hemolytic uremic syndrome (aHUS). In 2021, the long-…
[HTML][HTML] Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of Two-Year Efficacy and Safety Outcomes in Two Phase 3 Trials
BP Dixon, D Kavanagh, ADM Aris, B Adams, HG Kang… - Kidney Medicine, 2024 - Elsevier
8 天前 - … This research tested a drug called ravulizumab for the treatment of atypical hemolytic
uremic syndrome (aHUS). aHUS is a rare disease that causes clots in tiny blood vessels. …
uremic syndrome (aHUS). aHUS is a rare disease that causes clots in tiny blood vessels. …
[PDF][PDF] An Atypical Case of Hemolytic Uremic Syndrome Caused by Shiga Toxin Produced by Aeromonas spp.
SR Kreik - Cureus, 2024 - cureus.com
15 天前 - … Hemolytic uremic syndrome (HUS), traditionally recognized in pediatric populations,
is characterized by renal insufficiency, hemolytic anemia, and thrombocytopenia, often …
is characterized by renal insufficiency, hemolytic anemia, and thrombocytopenia, often …
Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature
R Sepúlveda Palamara… - Expert Review of …, 2024 - Taylor & Francis
16 天前 - … Comprehensive information about atypical hemolytic uremic syndrome (aHUS)
is relatively scarce outside of Europe and North America. This narrative review assembles …
is relatively scarce outside of Europe and North America. This narrative review assembles …
A Case of Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome
K Opare-Addo, S Ibrahim, B Addo… - Annals of Internal …, 2024 - acpjournals.org
17 天前 - … Atypical hemolytic uremic syndrome is a rare adverse effect of carfilzomib … hemolysis,
thrombocytopenia, and acute kidney injury (AKI) (1). Atypical hemolytic uremic syndrome …
thrombocytopenia, and acute kidney injury (AKI) (1). Atypical hemolytic uremic syndrome …
The Role of Complement in Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
M Vivarelli, J Barratt, LH Beck Jr, F Fakhouri, DP Gale… - Kidney International, 2024 - Elsevier
18 天前 - … While complement activation plays a causal role in atypical hemolytic uremic
syndrome (aHUS) and C3 glomerulopathy (C3G), over the past decade a rapidly accumulating …
syndrome (aHUS) and C3 glomerulopathy (C3G), over the past decade a rapidly accumulating …
Atypical Hemolytic Uremic Syndrome Triggered by COVID-19 Infection in a Pediatric Patient with CD46 Mutation
PM Dana, P Lorestani, MR Tohidi - 2024 - researchsquare.com
18 天前 - … In conclusion, this case report illustrates the potential for COVID-19 infection to
trigger episodes of atypical hemolytic uremic syndrome, particularly in patients with underlying …
trigger episodes of atypical hemolytic uremic syndrome, particularly in patients with underlying …
IgM autoantibodies to complement factor H in C3 glomerulopathy
M Cugno, MC Mancuso, F Depetri, F Peyvandi… - Journal of …, 2024 - Springer
20 天前 - … Following the identification of autoantibodies of the IgM class to the active site of
factor H in patients with atypical hemolytic uremic syndrome (aHUS) [1], we have searched for …
factor H in patients with atypical hemolytic uremic syndrome (aHUS) [1], we have searched for …
АКУШЕРСКИЙ ГЕМОЛИТИКО-УРЕМИЧЕСКИЙ СИНДРОМ, АССОЦИИРОВАННЫЙ С БЕРЕМЕННОСТЬЮ, У ПАЦИЕНТКИ С ИНФЕКЦИЕЙ И МАССИВНЫМ …
ЕН Васильковская, ЕИ Кутефа… - Вестник СурГУ …, 2024 - surgumed.ru
23 天前 - … haemorrhage, infection of the amniotic cavity and fetal membranes, sepsis,
atypical hemolytic uremic syndrome, multiple organ dysfunction Code: 3.3.3. Pathophysiology. …
atypical hemolytic uremic syndrome, multiple organ dysfunction Code: 3.3.3. Pathophysiology. …